Long-term prognosis of patients with hepatitis B virus–related acute-on-chronic liver failure: a retrospective study

Table 4 Risk factors for long-term prognosis in HBV-ACLF patients

	Univariate analysis	P value	Multivariate analysis	P value
	COR (95% CI)	P value	AOR (95% CI)	P value
Age	1.055 (1.034, 1.077)	< 0.001	1.043 (1.018, 1.068)	0.001
Cirrhosis	3.973 (2.553, 6.352)	< 0.001	3.675 (2.408, 6.594)	< 0.001
AST	0.999 (0.999, 1.000)	0.006
CHE	1.000 (1.000, 1.000)	< 0.001
TBIL	1.001 (1.000, 1.002)	0.210
PT	1.004 (0.985, 1.019)	0.603
Cr	1.002 (0.999, 1.005)	0.197
PLT	0.992 (0.988, 0.996)	< 0.001	0.994 (0.989, 0.999)	0.020
lgHBV DNA	0.865 (0.776, 0.963)	0.009
MELD score	1.075 (1.031, 1.120)	0.001
ALSS	0.542 (0.283, 0.963)	0.049

AST aspartate aminotransferase, CHE cholinesterase, TBIL total bilirubin, PT prothrombin time, Cr creatinine, PLT platelets, MELD model for end-stage liver disease, ALSS artificial liver support system, AOR adjusted odds ratio, COR crude odds ratio

ISSN: 1471-230X